Nuclear imaging probes have been explored as a diagnostic tool to detect brain AD pathology, including amyloid-β (Aβ) plaques3,4 and tau neurofibrillary tangles (NFTs)5,.6 The gene discussed is MAPT; the disease is Alzheimer disease.